일회용 의료기기 센서 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the disposable medical device sensors market size was valued at USD 9.92 billion in 2025 and estimated to grow from USD 11.03 billion in 2026 to reach USD 18.74 billion by 2031, at a CAGR of 11.18% during the forecast period (2026-2031).

This report is Segmented by Product (Biosensors, Image Sensors, Accelerometers, Pressure Sensors, and More), Application (Patient Monitoring, and More), End-User (Hospitals & Clinics, and More), Technology (MEMS, CMOS, and More), Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Disposable Medical Devices Sensors Market Trends and Insights

Growing Prevalence of Chronic Diseases

The number of adults living with diabetes exceeded 537 million in 2024, spurring unprecedented demand for disposable glucose-monitoring sensors such as Abbott's FreeStyle Libre, which supports more than 6 million users across 60 countries. Providers increasingly favor single-use cardiac sensors for long-term rhythm assessment as cardiovascular disease remains the top global mortality cause. Continuous, disposable solutions remove sterilization tasks and maintain accuracy over extended use, supporting chronic-care protocols for aging populations. As health systems pivot from episodic to continuous care, the disposable medical device sensors market gains an enduring revenue stream from refill demand.

Rising Demand for Point-of-Care Diagnostics

The pandemic reinforced the clinical value of near-patient testing, and disposable biosensors proved essential for rapid antigen detection in emergency departments and rural clinics. U.S. regulators continue to ease market entry by granting expedited pathways for qualified point-of-care devices, enhancing speed to market. Smartphone-connected sensor sticks permit immediate readouts and cloud upload, reshaping diagnostic data flows. Faster diagnosis trims patient wait times, cuts downstream costs, and elevates clinical outcome expectations, ensuring a sustained lift for the disposable medical device sensors market.

Stringent Regulatory Approval Process

New U.S. Quality System Regulation rules, effective February 2026, add clinical and documentation burdens that may lengthen time-to-market for smaller innovators. Interoperability guidelines now require compliance evidence during premarket submissions, driving extra verification costs. As harmonization across regions remains limited, firms must navigate multiple approval tracks, which can delay global releases and temporarily moderate growth for the disposable medical device sensors market.

Other drivers and restraints analyzed in the detailed report include:

1. Expansion of Wearable Health Monitoring Devices
2. Technological Advancements in Biosensor Miniaturization
3. Concerns Over Data Privacy and Security

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Biosensors captured 48.12% of revenue in 2025, reinforcing their role as the principal growth engine of the disposable medical device sensors market. Electrochemical formats dominate glucose and cardiac-marker monitoring, while optical biosensors accelerate infectious-disease screening where rapid turnaround is critical. Image sensors hold the fastest 13.38% CAGR because advances in compact CMOS chips elevate capsule endoscopy and single-use scopes, broadening clinical reach. Pressure sensors remain staples in intensive-care units, replacing reusable transducers that require calibration. Accelerometers, temperature probes and hybrid devices complete an expanding toolkit for multi-parameter monitoring in hospital and home settings.

Patient monitoring held 46.05% of 2025 revenue as hospitals and payers endorsed continuous surveillance for chronic ailments and post-procedure recovery. Remote monitoring codes in the United States underpin large-scale rollouts, pushing disposable medical device sensors market share steadily higher in this category. Diagnostics, however, shows the sharpest 14.11% CAGR as point-of-care platforms shift testing from centralized labs to bedsides, retail clinics and even homes. Rapid antigen assays and lab-on-a-chip cartridges reduce diagnosis time from hours to minutes, improving triage and containment efforts.

Complete Report Scope:

• By Product
  • Biosensors
    • Electrochemical Biosensors
    • Optical Biosensors
  • Image Sensors
  • Accelerometers
  • Pressure Sensors
  • Temperature Sensors
  • Other Products
• By Application
  • Patient Monitoring
  • Diagnostics
  • Therapeutics
• By End-User
  • Hospitals & Clinics
  • Home-care Settings
  • Diagnostic Laboratories
  • Ambulatory Surgical Centers
  • Research & Academic Institutes
• By Technology
  • MEMS
  • CMOS
  • 3-D Printed Polymeric Sensors
  • Nanotechnology-enabled Sensors
  • RFID / NFC Tags
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 38.21% of global revenue in 2025, sustained by sophisticated payer systems and rapid RPM reimbursement expansion. FDA exemptions for specific device classes shorten approval cycles and invite continued innovation. Leading providers integrate sensor data with electronic health records, demanding standardized communication protocols and boosting uptake across hospital networks.

Asia-Pacific is projected to register a 12.29% CAGR through 2031, the fastest worldwide. Government investment in public health infrastructure, a soaring chronic-disease burden, and rising consumer purchasing power fuel demand. China's updated reimbursement policies and India's cost-driven innovation culture provide fertile ground for local producers, challenging incumbent multinationals. Although venture financing cooled from prior peaks, strategic investors still back firms with differentiated, affordable solutions, enlarging total addressable volume for the disposable medical device sensors market.

Europe shows consistent growth supported by the EU Medical Device Regulation, which embeds environmental requirements that accelerate biodegradable sensor adoption. Sustainability mandates cause firms to redesign products and supply chains, spawning collaboration between materials scientists and device makers. The Middle East, Africa, and South America collectively offer untapped opportunities as hospital construction and universal health-coverage initiatives gather pace. Suppliers that tailor rugged, low-cost disposables to local conditions stand to capture early mover advantages and strengthen global diversity in the disposable medical device sensors market.

1. Medtronic
2. GE Healthcare
3. Koninklijke Philips
4. Abbott Laboratories
5. Honeywell International
6. NXP Semiconductors
7. Sensirion
8. Dexcom
9. Roche
10. OmniVision Technologies Inc.
11. STMicroelectronics
12. TDK InvenSense
13. Smiths Group
14. Starboard Medical Inc.
15. Shenzhen Med-Link Electronics
16. Medical Sensors India Pvt. Ltd.
17. Tekscan Inc.
18. Nova Biomedical
19. Lifescan
20. Cardea Bio (Paragraf)
21. Gentag

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Prevalence of Chronic Diseases
  • 4.2.2 Rising Demand for Point-of-Care Diagnostics
  • 4.2.3 Expansion of Wearable Health Monitoring Devices
  • 4.2.4 Technological Advancements in Biosensor Miniaturization
  • 4.2.5 Increasing Adoption in Emerging Markets
  • 4.2.6 Supportive Government and Reimbursement Policies
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulatory Approval Process
  • 4.3.2 Concerns Over Data Privacy And Security
  • 4.3.3 Price Sensitivity in Cost-Constrained Settings
  • 4.3.4 Limited Standardization and Interoperability
• 4.4 Regulatory Landscape
• 4.5 Porter's Five Forces Analysis
  • 4.5.1 Threat of New Entrants
  • 4.5.2 Bargaining Power of Buyers
  • 4.5.3 Bargaining Power of Suppliers
  • 4.5.4 Threat of Substitutes
  • 4.5.5 Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product
  • 5.1.1 Biosensors
    • 5.1.1.1 Electrochemical Biosensors
    • 5.1.1.2 Optical Biosensors
  • 5.1.2 Image Sensors
  • 5.1.3 Accelerometers
  • 5.1.4 Pressure Sensors
  • 5.1.5 Temperature Sensors
  • 5.1.6 Other Products
• 5.2 By Application
  • 5.2.1 Patient Monitoring
  • 5.2.2 Diagnostics
  • 5.2.3 Therapeutics
• 5.3 By End-User
  • 5.3.1 Hospitals & Clinics
  • 5.3.2 Home-care Settings
  • 5.3.3 Diagnostic Laboratories
  • 5.3.4 Ambulatory Surgical Centers
  • 5.3.5 Research & Academic Institutes
• 5.4 By Technology
  • 5.4.1 MEMS
  • 5.4.2 CMOS
  • 5.4.3 3-D Printed Polymeric Sensors
  • 5.4.4 Nanotechnology-enabled Sensors
  • 5.4.5 RFID / NFC Tags
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and analysis of Recent Developments)
  • 6.3.1 Medtronic plc
  • 6.3.2 GE Healthcare
  • 6.3.3 Koninklijke Philips N.V.
  • 6.3.4 Abbott Laboratories
  • 6.3.5 Honeywell International Inc.
  • 6.3.6 NXP Semiconductors
  • 6.3.7 Sensirion AG
  • 6.3.8 Dexcom Inc.
  • 6.3.9 F. Hoffmann-La Roche Ltd.
  • 6.3.10 OmniVision Technologies Inc.
  • 6.3.11 STMicroelectronics
  • 6.3.12 TDK InvenSense
  • 6.3.13 Smiths Medical
  • 6.3.14 Starboard Medical Inc.
  • 6.3.15 Shenzhen Med-Link Electronics
  • 6.3.16 Medical Sensors India Pvt. Ltd.
  • 6.3.17 Tekscan Inc.
  • 6.3.18 Nova Biomedical
  • 6.3.19 LifeScan Inc.
  • 6.3.20 Cardea Bio (Paragraf)
  • 6.3.21 Gentag Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment